Evox Therapeutics Appoints Dr Sonya Montgomery as Chief Medical Officer |
May 19, 2020 | May 2020 Bond Updates |
OXFORD, England, May 19, 2020 /PRNewswire/ -- Evox Therapeutics Ltd ('Evox' or the 'Company'), a leading exosome therapeutics company, is pleased to announce the appointment of Sonya Montgomery in the newly formed position of Chief Medical Officer. Sonya will provide translational,... |
View more at: https://www.prnewswire.com:443/news-releases/evox-therapeutics-appoints-dr-sonya-montgomery-as-chief-medical-officer-301060705.html |
Related News |
|